When Tomahawk shut down in 2016, it was powered by a team of six. A decade later, developer J Herskowitz has vibe-coded it ...

Explore the future of embedded systems development with Claude Code. Learn how AI tools could deliver high-quality code faster.

Let me show you how to turn Ubuntu into a powerful development environment for any project in just a few minutes!

Simply enter the code into the locker to get the Pressure Hand attachment for the GrabPack. Now, you can use the Pressure ...

Learn how to improve coding assignments with clear documentation, better structure, and professional formatting for higher grades and clarity.

Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...

A New York judge on Friday extended a preliminary injunction blocking the Trump administration from slashing funds to social service programs in five Democrat-led states. U.S. District Judge Vernon ...

Congress took steps on Wednesday toward blocking changes to D.C.’s local tax code, even as District officials warned it could wreak havoc on tax season and smash a hole in the city’s budget. The House ...

Both Polymarket and Kalshi announced free grocery stunts in NYC. Kalshi launched a $50 grocery giveaway at an East Village grocery store on Tuesday. Polymarket says it's doing its own pop-up, calling ...

A federal judge in Washington has blocked the Trump administration from closing down a humanitarian program that allowed around 350,000 Haitians to live and work legally in the U.S., according to ...

Fullerton has launched its new city-operated ambulance transportation program. Under the model, fire personnel will manage the full emergency response, from initial patient contact to transport to a ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.